impact factor, citescore
logo
 

One year in review

 

One year in review 2019: fibromyalgia


1, 2, 3, 4, 5, 6, 7, 8, 9, 10

 

  1. Rheumatology Unit, University of Messina, Italy. atzenifabiola@hotmail.com
  2. Clinical Pharmacology and Toxicology, University of Milan, Italy.
  3. Orthopaedic and Trauma Unit, Santissima Trinità Hospital, Cagliari, Italy.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  5. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  6. Rheumatology Unit, University of Messina, Italy
  7. Department of Internal Medicine and Medical Specialities, Rheumatology Unit Sapienza University of Rome, Italy.
  8. Department of Internal Medicine and Medical Specialities, Rheumatology Unit Sapienza University of Rome, Italy.
  9. Department of Internal Medicine and Medical Specialities, Rheumatology Unit Sapienza University of Rome, Italy.
  10. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

CER12100
2019 Vol.37, N°1 ,Suppl.116
PI 0003, PF 0010
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 30747097 [PubMed]

Received: 21/01/2019
Accepted : 23/01/2019
In Press: 06/02/2019
Published: 08/02/2019

Abstract

Fibromyalgia is characterised by chronic pain, fatigue and functional symptoms. Its aetiopathogenesis is still a matter of debate, but various pharmacological and non-pharmacological therapies are currently available for its treatment. We review the literature concerning the most recent findings related to the aetiopathogenesis, diagnosis, clinical aspects and treatment of FM published between January 2018 and January 2019.

Rheumatology Article